Sepsis Diagnostics Market
Number of pages: 100 | Report Format: PDF | Published date: March 14, 2023
Historical Years – 2021 | Base Year – 2022 | Forecasted Years – 2023-2031
|
Report Attribute |
Details |
|
Market Size Value in 2022 |
US$ 544.94 million |
|
Revenue Forecast in 2031 |
US$ 1,145.06 million |
|
CAGR |
8.6% |
|
Base Year for Estimation |
2022 |
|
Forecast Period |
2023-2031 |
|
Historical Year |
2021 |
|
Segments Covered |
Product, Technology, Pathogen, Testing Type, Method, End user, and Region |
|
Regional Scope |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
According to the deep-dive market assessment study by Growth Plus Reports, the global sepsis diagnostics market was valued at US$ 544.94 million in 2022 and is expected to register a revenue CAGR of 8.6% to reach US$ 1,145.06 million by 2031.
Sepsis Diagnostics Market Fundamentals
Sepsis is a potentially fatal illness induced by the body’s strong reaction to an infection. Early and accurate sepsis identification is crucial for successful treatment and better patient outcomes. Sepsis is often diagnosed using a combination of clinical and laboratory studies/research, such as blood cultures, white blood cell count, and lactate level assessments. Imaging tests, such as X-rays or ultrasounds, and biomarker tests identifying particular proteins or molecules linked with sepsis can also be employed as diagnostic techniques. It is vital to highlight that the symptoms of sepsis can be non-specific and overlap with other illnesses, making identification difficult. To help with sepsis diagnosis, healthcare practitioners employ various standards and scoring systems, including the qSOFA score and the Sepsis-3 criteria. Timely and accurate sepsis diagnosis is critical for initiating appropriate treatment and preventing potential complications.
[54654]
Sepsis Diagnostics Market Dynamics
The sepsis diagnostics market is expected to show lucrative growth during the projected timeframe due to the rising prevalence of sepsis among the population. Moreover, increasing cases of infections associated with sepsis further drive the market revenue growth. Additionally, with the rapid increase in hospital-associated infections globally, the necessity for suitable sepsis diagnostic devices is expected to grow in the near future. As a result, increased rates of hospital-associated infections are likely to boost the expansion of the sepsis diagnostics market.
Sepsis is also considered one of the major leading causes of mortality. Thus, there is an increasing need for advanced/evolved biomarkers to diagnose patients at high risk of complications early. It also assists in monitoring the disease’s progress, resulting in the appropriate therapy and enhancement in patient outcomes. The market is expected to be driven by advancements in diagnostics and medical technology, a rise in initiatives by government and/or private organizations to increase awareness, and growth in government funding.
However, the high cost of the treatment, lack of skilled professionals, and comparatively low awareness of novel technologies are expected to hamper the market revenue growth to some extent.
Sepsis Diagnostics Market Ecosystem
The global sepsis diagnostics market has been analyzed from seven perspectives: product, technology, pathogen, testing type, method, end user, and region.
Sepsis Diagnostics Market by Product
[64564]
Based on the product, the global sepsis diagnostics market can be segmented into instruments, blood culture media, assay kits and reagents, and software.
The blood culture media segment is expected to dominate the global market with the largest revenue share in 2022, as the blood culture medium is the primary approach for sepsis testing to characterize infections quickly and precisely. Most physicians highly recommend the blood culture media product as it is inexpensive.
The assay kits and reagents segment is projected to rise during the forecast period, due to the continuous launch of new and advanced technologies during the projection period.
Sepsis Diagnostics Market by Technology
Based on the technology, the global sepsis diagnostics market can be further segmented into microbiology, molecular diagnostics, immunoassays, flow cytometry, and others.
The molecular diagnostics segment dominates the global market with the largest revenue share. The molecular diagnostics segment can be further sub-segmented into polymerase chain reaction, DNA microarrays, syndromic panel testing, and others. The molecular diagnostics segment is expected to grow due to increased usage of this diagnostics technology owing to its several advantages over other technologies, such as high sensitivity, accuracy, and shorter turnaround time. However, this approach has the disadvantage of being unable to identify uncultivable species.
Sepsis Diagnostics Market by Pathogen
Based on the pathogen, the global sepsis diagnostics market can be further segmented into bacterial sepsis, fungal sepsis, viral sepsis, and others.
The bacterial sepsis segment registered for the largest revenue share in the global market in 2022. The segment is further sub-segmented into gram-negative bacterial sepsis and gram-positive bacterial sepsis. The high incidence of bacterial sepsis drives demand for sepsis diagnostics, including bacterial identification and susceptibility testing tests. Additionally, early detection of sepsis is crucial for improving patient outcomes, as delayed or missed diagnosis can result in severe complications and even result in increased mortality rates due to its rapid growth, thus, causing severe organ damage in a short period.
Several diagnostic tests are available for identifying bacterial sepsis, including blood cultures, molecular assays, and immunoassays. These tests can identify specific bacteria causing the infection and determine their antibiotic susceptibility, allowing for targeted and effective treatment. The availability of these specific diagnostic tests for bacterial sepsis further drives demand opportunities in the sepsis diagnostics market. Growing awareness of sepsis as a global health threat also led to increased funding and research into sepsis diagnostics. Governments and healthcare organizations worldwide are prioritizing sepsis prevention, early diagnosis, and effective treatment, which is driving demand for sepsis diagnostics, including those for bacterial sepsis.
Sepsis Diagnostics Market by Testing Type
Based on the testing type, the global sepsis diagnostics market can be segmented into laboratory testing and point-of-care testing.
The laboratory testing segment accounts for the largest revenue share of the global market. The growth of this segment can be attributed to the growing number of diagnostics laboratories with an increasing number of blood culture tests due to the high preference rate of laboratory testing among physicians. Laboratory testing is extremely accurate and dependable, and it can identify even trace amounts of bacteria or other pathogens in patient samples. This makes it a useful tool for detecting sepsis, which frequently necessitates the rapid and accurate diagnosis of the underlying illness.
Blood cultures, molecular assays, and immunoassays are among the laboratory tests for sepsis diagnosis. Each of these tests has advantages and disadvantages, but combined, they provide a comprehensive set of techniques for detecting sepsis. Most hospitals and healthcare facilities already have a well-established laboratory infrastructure, including qualified employees, equipment, and supplies. This enables incorporating sepsis diagnostic tests into current laboratory operations quite simply. Laboratory testing is frequently more cost-effective in the long term than other diagnostic approaches. Although acquiring equipment and supplies might be expensive, the ongoing expenses of administering tests are generally cheap, especially when compared to the cost of treating sepsis consequences. Several laboratory tests used in sepsis diagnosis have previously obtained FDA regulatory clearance, making them more generally recognized by healthcare providers and insurance. Automation and enhanced molecular testing procedures, among other advances in laboratory technology, have enabled sepsis diagnosis to be faster and more accurate than ever before. This has increased the need for laboratory testing in the sepsis diagnostics market.
Sepsis Diagnostics Market by Method
Based on the method, the global sepsis diagnostics market can be segmented into automated diagnostics and conventional diagnostics.
The conventional diagnostics segment is expected to account for the largest market revenue share during the forecast period. Due to the low cost, conventional methods for sepsis diagnosis are still the most preferred, leading to timely changes in the appropriate therapy.
Automated diagnostics can deliver faster results than traditional diagnostic methods, allowing healthcare providers to begin treatment earlier and potentially improve patient outcomes. Automated diagnostic systems use advanced algorithms and machine learning to improve accuracy and reduce the risk of false positives or false negatives. Automated diagnostics can provide a standardized approach to sepsis diagnosis, helping to reduce variability and improve the consistency of diagnostic results across different healthcare settings. Automated diagnostic systems can reduce the workload of healthcare providers and streamline the diagnostic process, leading to increased efficiency and reduced costs. By improving efficiency and reducing the need for additional diagnostic testing, automated diagnostics may be able to deliver cost savings over traditional diagnostic methods.
Sepsis Diagnostics Market by End User
Based on the end user, the global sepsis diagnostics market can be further segmented into home-based users, assisted living facilities, hospitals, and others.
The hospital segment accounts for the largest revenue share in the global market. The growth of this segment can be majorly attributed high preference rate among people with the rapid rise in the cases of sepsis among the population. Additionally, the availability of advanced healthcare facilities and services, and the continuously developing healthcare system further drive the revenue growth of the global market. Moreover, the availability of well-trained professionals with the highest patient satisfaction rate further encourages the segment's development, thereby propelling the overall market.
Sepsis Diagnostics Market by Region
Based on the region, the global sepsis diagnostics market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
North America registers the largest revenue share in the global sepsis diagnostics market due to the rise in the prevalence of sepsis cases among people causing a high rate of fatalities. Additionally, the availability of highly developed healthcare systems, many product launches and innovations, and an increase in research and development further stimulate the market revenue growth in this region.
Asia Pacific is the fastest emerging region and is expected to show lucrative growth during the forecast period due to the growth in the number of product approvals and the increase in the R&D funding for advanced diagnostic solutions. China and Japan account for the larger revenue share in the region, owing to their fast economic growth. Furthermore, the increasing death rate due to sepsis is a major factor driving the demand for sepsis diagnosis in these nations.
Sepsis Diagnostics Market Competitive Landscape
The prominent players operating in the global sepsis diagnostics market are:
Sepsis Diagnostics Market Strategic Developments
The global sepsis diagnostics market was valued at US$ 544.94 million in 2022
The molecular diagnostics segment dominates the global sepsis diagnostics market with the largest revenue share.
The global sepsis diagnostics market is expected to reach US$ 1,145.06 million by 2031.
The high cost of the treatment, lack of skilled professionals, and comparatively low awareness of novel technologies are expected to hamper the revenue growth of the global market.
Some players operating in the global sepsis diagnostics market are GE Healthcare, Koninklijke Philips N.V., Thermo Fisher Scientific, Inc., and Becton, Dickinson, and Company.
*Insights on financial performance are subject to the availability of information in the public domain